These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9775485)

  • 41. Digital rectal examination is barrier to population-based prostate cancer screening.
    Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL
    Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
    Morlando M; Pelullo CP; Di Giuseppe G
    PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of prostate cancer screening in a comprehensive community cancer center.
    Dillman RO; Williams T
    Cancer Invest; 1994; 12(5):456-62. PubMed ID: 7522939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of prostate cancer screening among health fair participants.
    Chiu BC; Anderson JR; Corbin D
    Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of prostatic specific antigen in prostate cancer screening in the community.
    Jubelirer SJ; Tierney JP; Oliver S; Serrato JM; Farra S; Plymale J; Hodge E
    W V Med J; 1994 Apr; 90(4):140-2. PubMed ID: 7516602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.
    Auvinen A; Tammela T; Stenman UH; Uusi-Erkkilä I; Leinonen J; Schröder FH; Hakama M
    Br J Cancer; 1996 Aug; 74(4):568-72. PubMed ID: 8761371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
    Reissigl A; Horninger W; Fink K; Klocker H; Bartsch G
    Cancer; 1997 Nov; 80(9):1818-29. PubMed ID: 9351555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thinking Style as a Predictor of Men's Participation in Cancer Screening.
    McGuiness CE; Turnbull D; Wilson C; Duncan A; Flight IH; Zajac I
    Am J Mens Health; 2017 Mar; 11(2):318-329. PubMed ID: 27923966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomised trial of prostate cancer screening in The Netherlands: assessment of acceptance and motives for attendance.
    Nijs HG; Tordoir DM; Schuurman JH; Kirkels WJ; Schröder FH
    J Med Screen; 1997; 4(2):102-6. PubMed ID: 9275269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obstacles to prostate cancer screening in African-American men.
    Boyd MD; Weinrich SP; Weinrich M; Norton A
    J Natl Black Nurses Assoc; 2001 Dec; 12(2):1-5. PubMed ID: 11902015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers to prostate cancer screening.
    Weinrich SP; Reynolds WA; Tingen MS; Starr CR
    Cancer Nurs; 2000 Apr; 23(2):117-21. PubMed ID: 10763282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An exploration of screening practices for prostate cancer and the associated community expenditure.
    Perkins JJ; Sanson-Fisher RW; Clarke SJ; Youman P
    Br J Urol; 1998 Oct; 82(4):524-9. PubMed ID: 9806181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A national survey of medical students' beliefs and knowledge in screening for prostate cancer.
    Marcella S; Delnevo CD; Coughlin SS
    J Gen Intern Med; 2007 Jan; 22(1):80-5. PubMed ID: 17351844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of compliance with prostate cancer screening guidelines.
    Grubb RL; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2005 Aug; 174(2):668-72; discussion 672. PubMed ID: 16006944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
    Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
    Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.